K.-M. Deppermann

458 total citations
15 papers, 183 citations indexed

About

K.-M. Deppermann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, K.-M. Deppermann has authored 15 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in K.-M. Deppermann's work include Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). K.-M. Deppermann is often cited by papers focused on Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). K.-M. Deppermann collaborates with scholars based in Germany and United States. K.-M. Deppermann's co-authors include P. Koeppe, H. Lode, G. Höffken, Keikawus Arastéh, Gudrun Bornhöft, Marina Stöffler-Meilicke, Julia Lepenies, Michael Boeckh, W. Heise and B Bieniek and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

K.-M. Deppermann

14 papers receiving 167 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.-M. Deppermann Germany 7 78 54 49 38 28 15 183
M. Cesana Italy 12 121 1.6× 37 0.7× 38 0.8× 109 2.9× 29 1.0× 28 332
Barbara Wilson United States 12 70 0.9× 19 0.4× 84 1.7× 29 0.8× 48 1.7× 29 308
Shirley K. Seo United States 10 58 0.7× 22 0.4× 10 0.2× 34 0.9× 60 2.1× 27 289
Ray Chung United States 7 143 1.8× 18 0.3× 18 0.4× 17 0.4× 39 1.4× 10 283
Karina Sánchez-Reyes Mexico 11 39 0.5× 59 1.1× 15 0.3× 14 0.4× 120 4.3× 20 314
Simbarashe Zvada South Africa 9 72 0.9× 36 0.7× 6 0.1× 68 1.8× 41 1.5× 12 276
Naadira Vanker South Africa 7 54 0.7× 11 0.2× 9 0.2× 20 0.5× 20 0.7× 11 154
Tieying Sun China 6 58 0.7× 21 0.4× 65 1.3× 33 0.9× 35 1.3× 11 212
Matthew Routledge United Kingdom 6 80 1.0× 33 0.6× 22 0.4× 30 0.8× 56 2.0× 9 310
Jean-Pierre Kains Belgium 6 29 0.4× 62 1.1× 27 0.6× 38 1.0× 28 1.0× 12 197

Countries citing papers authored by K.-M. Deppermann

Since Specialization
Citations

This map shows the geographic impact of K.-M. Deppermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-M. Deppermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-M. Deppermann more than expected).

Fields of papers citing papers by K.-M. Deppermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.-M. Deppermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-M. Deppermann. The network helps show where K.-M. Deppermann may publish in the future.

Co-authorship network of co-authors of K.-M. Deppermann

This figure shows the co-authorship network connecting the top 25 collaborators of K.-M. Deppermann. A scholar is included among the top collaborators of K.-M. Deppermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-M. Deppermann. K.-M. Deppermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Heigener, David F., K.-M. Deppermann, Martin Sebastian, & Martin Reck. (2011). Stadieneinteilung des nichtkleinzelligen Lungenkarzinoms. Der Onkologe. 17(8). 679–683.
3.
Reck, Martin, Joachim von Pawel, J.R. Fischer, et al.. (2010). Erlotinib versus carboplatin/vinorelbine in elderly patients (age 70 or older) with advanced non-small cell lung carcinoma (NSCLC): A randomized phase II study of the German Thoracic Oncology Working Group.. Journal of Clinical Oncology. 28(15_suppl). 7565–7565. 10 indexed citations
4.
Lübbe, A.S., et al.. (2008). Rehabilitation bei Patienten mit Lungenkarzinom. Pneumologie. 62(8). 502–506. 5 indexed citations
5.
Niederle, N., K.-M. Deppermann, & M. Wolf. (2008). Systemische Therapie des kleinzelligen Lungenkarzinoms. Der Onkologe. 14(8). 783–791. 1 indexed citations
6.
Reck, Martin, K.-M. Deppermann, U. Gatzemeier, & N. Niederle. (2006). Nichtkleinzelliges Lungenkarzinom. Der Onkologe. 12(8). 761–768. 1 indexed citations
7.
Deppermann, K.-M., et al.. (2004). Managementstrategien bei der oberen Einflussstauung. Der Onkologe. 10(4). 325–333. 2 indexed citations
8.
9.
Deppermann, K.-M., et al.. (1997). 171 Paclitaxel (TAX) and carboplatin (CBDA) in advanced SCLC: A phase II study. Lung Cancer. 18. 46–46. 5 indexed citations
10.
Boeckh, Michael, Julia Lepenies, B Bieniek, et al.. (1996). High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. Journal of Clinical Microbiology. 34(2). 457–459. 45 indexed citations
11.
Papadopoulos, Georgios, et al.. (1994). Intraoperative trans�sophageale versus pr�operative transthorakale Kontrast-Echokardiographie. Der Anaesthesist. 43(9). 582–586. 6 indexed citations
12.
Roller, Shane, H. Lode, Ingeborg Stelzer, et al.. (1992). Pharmacokinetics of loracarbef and interaction with acetylcysteine. European Journal of Clinical Microbiology & Infectious Diseases. 11(9). 851–855. 5 indexed citations
13.
Boeckh, Michael, et al.. (1990). Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole. Antimicrobial Agents and Chemotherapy. 34(12). 2407–2414. 25 indexed citations
14.
Lode, H., et al.. (1990). Pharmacokinetics of FCE 22891, a new oral penem. Antimicrobial Agents and Chemotherapy. 34(6). 1001–1006. 7 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Cesana Breakdown of academic impact, for papers by Barbara Wilson Breakdown of academic impact, for papers by Shirley K. Seo Breakdown of academic impact, for papers by Ray Chung Breakdown of academic impact, for papers by Karina Sánchez-Reyes Breakdown of academic impact, for papers by Simbarashe Zvada Breakdown of academic impact, for papers by Naadira Vanker Breakdown of academic impact, for papers by Tieying Sun Breakdown of academic impact, for papers by Matthew Routledge Breakdown of academic impact, for papers by Jean-Pierre Kains
Rankless by CCL
2026